auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
University of OttawaDepartment
National Research Council CanadaAmount
$25.0K
Province
ONType
Grant
Agreement Number
172-2018-2019-Q4-00044
Purpose
Accumulation of toxic forms of alpha-synuclein plays a central role in the development of Parkinson's disease. We aim to harness the ability of cells' own nanovesicles to cross the blood-brain barrier, silence alpha-synuclein and protect nerve cells, paving the way for novel therapeutics for silencing key toxic genes in other neurodegenerative diseases
University of Ottawa × National Research Council Canada
169 grants totalling $50.4M
Collaborative Science, Technology and Innovation Program – Ideation Fund
449 grants totalling $30.0M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| The Governors of the University of Calgary | $856.8K | Collaborative Science, Technology and In... |
| The Governors of the University of Calgary | $856.8K | Collaborative Science, Technology and In... |
| The Governors of the University of Calgary | $856.8K | Collaborative Science, Technology and In... |
| The Governing Council of the University of Toronto | $753.0K | Collaborative Science, Technology and In... |
| University of Waterloo | $730.0K | Collaborative Science, Technology and In... |